Real-World Persistency for Inflammatory Bowel Disease Biologics Using Patient Registry Data

BACKGROUND: Although it is a truism that drugs benefit patients only when taken, surprisingly little is known about real-world drug-use persistence and discontinuation, even for expensive biologic drugs. METHODS: We used longitudinal self-reported drug-use data from the inflammatory bowel disease (I...

Descripción completa

Detalles Bibliográficos
Autores principales: Goss Sawhney, Tia, Dobes, Angela, O’Charoen, Sirimon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Observations and Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629214/
https://www.ncbi.nlm.nih.gov/pubmed/37941597
http://dx.doi.org/10.1093/crocol/otad051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629214/
https://www.ncbi.nlm.nih.gov/pubmed/37941597
http://dx.doi.org/10.1093/crocol/otad051

Ejemplares similares